Tritium and less energetic neutrons (only fission, deuterium-tritium fusion, and splitting are net neutron producers), lithium deuteride is not used in boosted bombs, but rather for multi-stage hydrogen bombs. Tritium is an important fuel for controlled nuclear fusion in both magnetic confinement and inertial confinement fusion reactor designs. The experimental fusion reactor ITER and the National Ignition Facility (NIF) will use deuterium-tritium fuel. The deuterium-tritium reaction is favorable since it has the largest fusion cross-section (about 5.0 barns) and it reaches this maximum cross-section at the lowest energy (about 65 keV center-of-mass) of any potential fusion fuel. The Tritium Systems Test
Board of Radiation and Isotope Technology also manufactures self-luminescent tritium filled sources. The organisation also develops radiation-based medical equipment to treat cancer. BRIT operates three radiation facilities, one of them a spice and allied products irradiation facility in Vashi and another a "Krushak" (Krishi Utpadan Sanrakshan Kendra) radiation processing plant at Nashik. G. Ganesh is BRIT's Chief Executive officer since 1 August 2015, succeeding Anil Kumar Kohli (2006-2015). Board of Radiation and Isotope Technology Board of Radiation and Isotope Technology in short known as "BRIT" is a unit of the Department of Atomic Energy with its headquarters in Navi Mumbai, India. It is involved in production,